Physician

Ian Ferguson, MD

According to 2025 Medicare claims, Ian Ferguson, MD (NPI: 1467912550) practices dermatology in the Everett, WA market, with the plurality of this provider's patient population coming from Snohomish, WA. This provider's primary affiliated billing organization is SILVER FALLS DERMATOLOGY, LLC (NPI: 1134375421; TIN: 262636087) and primary practice location at 98012-1797.

Ferguson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 427 traditional Medicare patients, billed 5,543 HCPCS/CPT codes, and received $82,779 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 787 prescription claims across 351 beneficiaries totaling $68,999 in drug costs, led by Dupixent Pen (Dupilumab). Open Payments data shows 49 records totaling $1,230. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $6,882 to $68,999. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$41K$83K2023 Medicare payment: $22,182 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $82,779 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023124902$22,182
20244275,543$82,779

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$34K$69K2019 Drug cost: $6,882 (USD; Tot_Drug_Cst)2020 Drug cost: $9,593 (USD; Tot_Drug_Cst)2021 Drug cost: $15,224 (USD; Tot_Drug_Cst)2022 Drug cost: $2,172 (USD; Tot_Drug_Cst)2023 Drug cost: $7,332 (USD; Tot_Drug_Cst)2024 Drug cost: $68,999 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
20191755$6,882
202069124$9,593
202183207$15,224
20222337$2,172
202373106$7,332
2024351787$68,999

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more105132$86
99203New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more102102$68
11102Biopsy of related skin growth, first growth104116$67
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more157191$59
17000Destruction of precancer skin growth, 1 growth120139$40

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Dupixent PenDupilumab12336$45,445
FluorouracilFluorouracil832,513$5,406
Clobetasol PropionateClobetasol Propionate953,090$3,365
KetoconazoleKetoconazole1384,393$2,403
TacrolimusTacrolimus17465$1,335

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.49$1,230GENZYME CORPORATION
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Ian Ferguson, MD?

Tedicare shows public-source Medicare data for Ian Ferguson, MD (NPI 1467912550), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ian Ferguson, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ian Ferguson, MD?

Ian Ferguson, MD is linked to SILVER FALLS DERMATOLOGY, LLC (billing NPI 1134375421) in the available physician profile data.

Does Ian Ferguson, MD have Open Payments data?

Ian Ferguson, MD has 49 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.